Sean Brynjelsen
Fortune : 30 M $ au 30/06/2026
Fortune : 30 M $ au 30/06/2026
Sean E.
Brynjelsen is President, Chief Executive Officer & Director at Eton Pharmaceuticals, Inc. since 2017.
Formerly, Senior Vice President-Global Business Development at Akorn, Inc. from 2015 to 2016, and Executive Vice President-Business Development at Sagent Pharmaceuticals, Inc. from 2016 to 2017.
Education includes an MBA from the University of Notre Dame in 2006, an undergraduate degree from the University of Illinois in 1993, and a graduate degree from the University of Illinois in 1995.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 833 694 ( 3,04 % ) | 30 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ETON PHARMACEUTICALS, INC. | Directeur Général | 01/06/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
| SAGENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01/06/2017 |
| AKORN, INC. | Directeur Technique/Scientifique/R&D | 07/02/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutic, diagnostic & surgical pharmaceuticals | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription drug products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national